Search
for
Sort by
Research 151–180 of 1000+
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Crystal Structure of 3-Oxo-4-Aza-5-Alpha-Androstone-17 β-Tert-Butyl Carboxamide with an O···H–(C, N) Acceptor Four-Center Hydrogen Bond
- Anti-androgenic therapy with finasteride in patients with chronic heart failure – a retrospective propensity score based analysis
- Dutasteride
- A Comprehensive Review on Phytochemistry and Pharmacological Effects of Stinging Nettle (Urtica dioica)
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Effect of Citrullus colocynthis Schard on Testosterone-Induced Benign Prostatic Hyperplasia
- Androgen receptors and their biology
- 5-Alpha reductase deficiency
- Male androgenetic alopecia (Part II)
- Clinical use of 5α-reductase inhibitors
- Androgen Receptor Ligands: Agonists and Antagonists
- Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
- Relatório de Estágio realizado na Farmácia Santiago
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- Hormonal manipulation of benign prostatic hyperplasia
- The Benefits of Dual Inhibition of 5α Reductase
- Persistent Gynecomastia due to Short-term Low-dose Finasteride for Androgenetic Alopecia
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- Antioxidant and Antiproliferative Activity of Finasteride against Glioblastoma Cells
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- Estrogen and androgen signaling in the pathogenesis of BPH
- Dutasteride: a guide to its use as monotherapy in benign prostatic hyperplasia
- Recent advances in treatment for Benign Prostatic Hyperplasia
- Pharmacological Effects of the Lipidosterolic Extract from Kigelia africana Fruits in Experimental Benign Prostatic Hyperplasia Induced by Testosterone in Sprague Dawley Rats
- Canine Sertoli cell tumor: anti-Müllerian hormone, inhibin B, and estrone sulphate
- Lower urinary tract symptoms (LUTS): The role of medications in improvement of quality of life